What is the main business of Damak?

The main business activity of Damak focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 9, 2011.

Where is the headquarters located?

The headquarters is located at: 29, 95-060 Paprotnia.

What is the share capital?

The share capital of the company is PLN 1,227,150 (approx. $331,483).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

The company reported a revenue of $21,879 in 2024, which is an increase of 98.9% compared to 2023.

No, the company recorded a net loss of $7,574 in 2024. For comparison, in 2023 the loss was $4,608, meaning the company increased its loss by 56.1%.

What is the main operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $12,069 in 2024, representing 41% of all operating expenses.

Damaksp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2011-12-09

Share capital

1,227,150.00 PLN

Registered address

29, 95-060 Paprotnia, Poland

Electronic delivery address

AE:PL-95389-75750-DRREF-29

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 26 days early.

2025filed
202408/07/2025
202311/07/2024
202226/06/2023
202101/07/2022
202021/07/2021

Filed on timeDelayFiling deadline

The statements for 2019 report only zeros (no activity).

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 28.13kMedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD -8.04kMedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 35.90kMedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 203.78kMedianUSD 609.79kAverageUSD 11.85m

Industry

Authorized Representatives

Anna Kieszkowska Ojasoo – Vice President

Mariola Kieszkowska – President of the Management Board

Manner of representation

In the case of a multi-member management board, declarations of will on behalf of the company may be made: in non-property matters and in property matters where the value of the transaction does not exceed 150,000.00 zlotys, by each member of the management board independently; in property matters where the value of the transaction exceeds 150,000.00 zlotys, joint action of at least two members of the management board or of a member of the management board jointly with a commercial proxy is required.

Ownership

Owner	Shares	Share value	Stake
Mariola Kieszkowskaage 69	5,009	$202,957.86	61.2272%
Anna Kieszkowska Ojasooage 46	3,172	$128,525.12	38.7728%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2012-01-01.

BNP Paribas Bank Polska
48 1600 1143 1843 8772 9000 0001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
OMET Medicalsp. z o.o.	$1,867,545.06	ometmedical.pl
Cytogen - Polskasp. z o.o.	$1,127,200.51	cytogen.com.pl
Goldfarmexsp. z o.o.	$710,510.28	goldfarmex.pl
Orthoactivesp. z o.o.	$617,449.08	orthoactive.pl
Tecnobody Polskasp. z o.o.	$508,641.92	mtt.net.pl
CanpolandS.A.	$328,824.15	canpoland.com
Geneco Groupsp. z o.o.	$156,220.50	genecocontact.pl
Novaova Sosnowski Wadowskisp. k.	$54,452.69	novaova.pl
Endolink PharmaS.A.	$7,191.18	endolink.pl
Novaovasp. z o.o.	$0.16	novaova.pl